FDA tests out ‘real-time’ clinical trials; AbbVie closes in on a KRAS biotech
Summary
Through two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it’s accrued. Elsewhere, Lilly inked a gene editing deal an...
Description
Through two pioneering studies, Amgen and AstraZeneca will share study data with FDA scientists as it’s accrued. Elsewhere, Lilly inked a gene editing deal an...
Original reporting
AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.
Open original source